A Study Of Contrast-enhanced Confocal Laser Endomicroscopy Imaging Of Breast Tissue With The InVue And InForm

Overview

About this study

The purpose of this study is to assess the safety and effectiveness of contrast-enhanced CLE imaging of breast tissue with the InVue and InForm systems.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients ≥18 years of age with biopsy proven invasive breast carcinoma or DCIS undergoing BCS as a primary treatment with or without cavity shave

Exclusion Criteria:

  • Patients with a history of allergy to fluorescein or hypersensitivity responses, or who are unable to complete study consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/09/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Johnson, M.D.

Contact us for the latest status

Contact information:

Breast Melanoma Oncology Research

(507) 538-4849

BMSORESEARCH@mayo.edu

More information

Publications

Publications are currently not available